Last updated on January 2010

Non-Small Cell Lung Cancer


Brief description of study

Non-Small Cell Lung Cancer

Detailed Study Description

Patients with non-small cell lung cancer who have failed two or more prior treatment regimens, to determine overall survival

Patient Inclusion Criteria:

  • 18+ years of age, confirmed stage IIIB or non-small cell lung cancer, failed at least 2 prior systemic anti-cancer regimens, disease progression,

Patient Exclusion Criteria:

  • Presence of brain metastases, inability to take oral medications, serious active infection, psychiatric illness that would limit study compliance.

Clinical Study Identifier: TX134702

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Dr. Tom Davis

Legacy Pharma Research
Bismarck, ND USA
  Connect »